TY - JOUR
T1 - Impact of Age on the Risk of Advanced Colorectal Neoplasia in a Young Population
T2 - An Analysis Using the Predicted Probability Model
AU - Jung, Yoon Suk
AU - Park, Chan Hyuk
AU - Kim, Nam Hee
AU - Lee, Mi Yeon
AU - Park, Dong Il
N1 - Publisher Copyright:
© 2017, Springer Science+Business Media, LLC.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Background: The incidence of colorectal cancer is decreasing in adults aged ≥50 years and increasing in those aged <50 years. Aims: We aimed to establish risk stratification model for advanced colorectal neoplasia (ACRN) in persons aged <50 years. Methods: We reviewed the records of participants who had undergone a colonoscopy as part of a health examination at two large medical examination centers in Korea. By using logistic regression analysis, we developed predicted probability models for ACRN in a population aged 30–49 years. Results: Of 96,235 participants, 57,635 and 38,600 were included in the derivation and validation cohorts, respectively. The predicted probability model considered age, sex, body mass index, family history of colorectal cancer, and smoking habits, as follows: YACRN = −8.755 + 0.080·Xage − 0.055·Xmale + 0.041·XBMI + 0.200·Xfamily_history_of_CRC + 0.218·Xformer_smoker + 0.644·Xcurrent_smoker. The optimal cutoff value for the predicted probability of ACRN by Youden index was 1.14%. The area under the receiver-operating characteristic curve (AUROC) values of our model for ACRN were higher than those of the previously established Asia–Pacific Colorectal Screening (APCS), Korean Colorectal Screening (KCS), and Kaminski’s scoring models [AUROC (95% confidence interval): model in the current study, 0.673 (0.648–0.697); vs. APCS, 0.588 (0.564–0.611), P < 0.001; vs. KCS, 0.602 (0.576–0.627), P < 0.001; and vs. Kaminski’s model, 0.586 (0.560–0.612), P < 0.001]. Conclusion: In a young population, a predicted probability model can assess the risk of ACRN more accurately than existing models, including the APCS, KCS, and Kaminski’s scoring models.
AB - Background: The incidence of colorectal cancer is decreasing in adults aged ≥50 years and increasing in those aged <50 years. Aims: We aimed to establish risk stratification model for advanced colorectal neoplasia (ACRN) in persons aged <50 years. Methods: We reviewed the records of participants who had undergone a colonoscopy as part of a health examination at two large medical examination centers in Korea. By using logistic regression analysis, we developed predicted probability models for ACRN in a population aged 30–49 years. Results: Of 96,235 participants, 57,635 and 38,600 were included in the derivation and validation cohorts, respectively. The predicted probability model considered age, sex, body mass index, family history of colorectal cancer, and smoking habits, as follows: YACRN = −8.755 + 0.080·Xage − 0.055·Xmale + 0.041·XBMI + 0.200·Xfamily_history_of_CRC + 0.218·Xformer_smoker + 0.644·Xcurrent_smoker. The optimal cutoff value for the predicted probability of ACRN by Youden index was 1.14%. The area under the receiver-operating characteristic curve (AUROC) values of our model for ACRN were higher than those of the previously established Asia–Pacific Colorectal Screening (APCS), Korean Colorectal Screening (KCS), and Kaminski’s scoring models [AUROC (95% confidence interval): model in the current study, 0.673 (0.648–0.697); vs. APCS, 0.588 (0.564–0.611), P < 0.001; vs. KCS, 0.602 (0.576–0.627), P < 0.001; and vs. Kaminski’s model, 0.586 (0.560–0.612), P < 0.001]. Conclusion: In a young population, a predicted probability model can assess the risk of ACRN more accurately than existing models, including the APCS, KCS, and Kaminski’s scoring models.
KW - Advanced colorectal neoplasia
KW - Predictive model
KW - Probability
KW - Young population
UR - https://www.scopus.com/pages/publications/85025431563
U2 - 10.1007/s10620-017-4683-y
DO - 10.1007/s10620-017-4683-y
M3 - Article
C2 - 28733868
AN - SCOPUS:85025431563
SN - 1573-2568
VL - 62
SP - 2518
EP - 2525
JO - Digestive diseases and sciences
JF - Digestive diseases and sciences
IS - 9
ER -